Literature DB >> 30675266

miR-885-5p suppresses osteosarcoma proliferation, migration and invasion through regulation of β-catenin.

Yan Liu1,2, Zili Bao2, Wanqing Tian2, Guicheng Huang1.   

Abstract

MicroRNAs (miRs) have been reported to serve key roles in cancer. To investigate the function of miR-885-5p in osteosarcoma, the expression levels of miR-885-5p were analyzed in 85 osteosarcoma tissue samples and adjacent non-cancerous tissue samples, using reverse transcription-quantitative polymerase chain reaction analysis. It was demonstrated that miR-885-5p was downregulated in osteosarcoma tissues and cell lines. Notably, the expression level of miR-885-5p was closely associated with tumor size, Tumor-Node-Metastasis stage and lymph node metastasis. Additionally, low expression levels of miR-885-5p also predicted a poor prognosis of osteosarcoma. To further decipher the roles of miR-885-5p in osteosarcoma, it was determined that β-catenin, a key component of the Wnt signaling pathway, was a target of miR-885-5p. Furthermore, several functional experiments, including a colony formation assay, CCK-8 assay, wound healing assay and Transwell invasion assay, revealed that miR-885-5p suppressed cell proliferation, migration and invasion through inhibition of β-catenin. The results of the present study provide a novel insight into the molecular roles of miR-885-5p in osteosarcoma.

Entities:  

Keywords:  invasion; microRNA-885-5p; migration; proliferation; β-catenin

Year:  2018        PMID: 30675266      PMCID: PMC6341799          DOI: 10.3892/ol.2018.9768

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  5 in total

1.  Feedback activation of GATA1/miR-885-5p/PLIN3 pathway decreases sunitinib sensitivity in clear cell renal cell carcinoma.

Authors:  Dayong Yao; Shunyao Xia; Chengjun Jin; Weiming Zhao; Wenjia Lan; Zan Liu; Youcheng Xiu
Journal:  Cell Cycle       Date:  2020-08-12       Impact factor: 4.534

2.  Synergistic Autophagy Effect of miR-212-3p in Zoledronic Acid-Treated In Vitro and Orthotopic In Vivo Models and in Patient-Derived Osteosarcoma Cells.

Authors:  Ju Yeon Oh; Eun Ho Kim; Yeon-Joo Lee; Sei Sai; Sun Ha Lim; Jang Woo Park; Hye Kyung Chung; Joon Kim; Guillaume Vares; Akihisa Takahashi; Youn Kyoung Jeong; Mi-Sook Kim; Chang-Bae Kong
Journal:  Cancers (Basel)       Date:  2019-11-18       Impact factor: 6.639

3.  Long Non-Coding RNA FEZF1-AS1 Modulates CXCR4 to Promote Cell Proliferation, Warburg Effect and Suppress Cell Apoptosis in Osteosarcoma by Sponging miR-144.

Authors:  Jun Liu; Guang Feng; Zhengwei Li; Rui Li; Peng Xia
Journal:  Onco Targets Ther       Date:  2020-04-05       Impact factor: 4.147

4.  MicroRNA expression and DNA methylation profiles do not distinguish between primary and recurrent well-differentiated liposarcoma.

Authors:  Melissa Vos; Ruben Boers; Anne L M Vriends; Joachim Boers; Patricia F van Kuijk; Winan J van Houdt; Geert J L H van Leenders; Michal Wagrodzki; Wilfred F J van IJcken; Joost Gribnau; Dirk J Grünhagen; Cornelis Verhoef; Stefan Sleijfer; Erik A C Wiemer
Journal:  PLoS One       Date:  2020-01-23       Impact factor: 3.240

5.  The ATO/miRNA-885-5p/MTPN axis induces reversal of drug-resistance in cholangiocarcinoma.

Authors:  Yuting Wang; Wen Zhang; Lin Chen; Wei Chen; Shufen Xu; Lingyu Tang; Yang Yang; Quanpeng Li; Qi Jiang; Lin Miao
Journal:  Cell Oncol (Dordr)       Date:  2021-06-25       Impact factor: 6.730

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.